These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 1318677)
61. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. Strigl S; Roblin PM; Reznik T; Hammerschlag MR Antimicrob Agents Chemother; 2000 Apr; 44(4):1112-3. PubMed ID: 10722526 [TBL] [Abstract][Full Text] [Related]
62. In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis. Talbot H; Romanowski B Antimicrob Agents Chemother; 1989 Dec; 33(12):2049-51. PubMed ID: 2533473 [TBL] [Abstract][Full Text] [Related]
63. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis]. Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718 [TBL] [Abstract][Full Text] [Related]
64. In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin. Johnson RC; Kodner C; Russell M; Girard D J Antimicrob Chemother; 1990 Jan; 25 Suppl A():33-8. PubMed ID: 2154436 [TBL] [Abstract][Full Text] [Related]
65. Comparative activities of amoxycillin, amoxycillin/clavulanic acid and tetracycline against Chlamydia trachomatis in cell culture and in an experimental mouse pneumonitis. Beale AS; Faulds E; Hurn SE; Tyler J; Slocombe B J Antimicrob Chemother; 1991 May; 27(5):627-38. PubMed ID: 1885420 [TBL] [Abstract][Full Text] [Related]
66. Antimicrobial Sensitivity Profile of Chlamydia trachomatis isolates from Croatia in McCoy Cell Culture System and Comparison with the Literature. Mestrović T; Ljubin-Sternak S; Sviben M; Bedenić B; Vranes J; Markotić A; Skerk V Clin Lab; 2016; 62(3):357-64. PubMed ID: 27156324 [TBL] [Abstract][Full Text] [Related]
67. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis. Segreti J; Kapell KS; Trenholme GM Diagn Microbiol Infect Dis; 1992; 15(4):371-3. PubMed ID: 1611854 [TBL] [Abstract][Full Text] [Related]
68. In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae. Roblin PM; Hammerschlag MR J Antimicrob Chemother; 1999 Oct; 44(4):549-51. PubMed ID: 10588319 [TBL] [Abstract][Full Text] [Related]
69. Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and the duration of the presence of antibiotics. Notomi T; Ikeda Y; Nagayama A Chemotherapy; 1999; 45(4):242-8. PubMed ID: 10394006 [TBL] [Abstract][Full Text] [Related]
70. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae. Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246 [TBL] [Abstract][Full Text] [Related]
71. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae. Jorgensen JH; Swenson JM; Tenover FC; Barry A; Ferraro MJ; Murray PR; Reller LB J Clin Microbiol; 1996 Nov; 34(11):2679-84. PubMed ID: 8897164 [TBL] [Abstract][Full Text] [Related]
72. In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae. Kohlhoff SA; Huband MD; Hammerschlag MR Antimicrob Agents Chemother; 2014 Dec; 58(12):7595-6. PubMed ID: 25288086 [TBL] [Abstract][Full Text] [Related]
73. Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis. Solomon AW; Mohammed Z; Massae PA; Shao JF; Foster A; Mabey DC; Peeling RW Antimicrob Agents Chemother; 2005 Nov; 49(11):4804-6. PubMed ID: 16251338 [TBL] [Abstract][Full Text] [Related]
74. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry. Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523 [TBL] [Abstract][Full Text] [Related]
77. [Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae]. Chevalier B; Crenn Y; Cavallo JD; Plotton N; Meyran M Pathol Biol (Paris); 1995 Apr; 43(4):281-3. PubMed ID: 7567115 [TBL] [Abstract][Full Text] [Related]
78. An in-vitro investigation of synergy and antagonism between antimicrobials against Chlamydia trachomatis. How SJ; Hobson D; Hart CA; Webster RE J Antimicrob Chemother; 1985 May; 15(5):533-8. PubMed ID: 4008386 [TBL] [Abstract][Full Text] [Related]
79. Effects of ascorbic acid on Chlamydia trachomatis infection and on erythromycin treatment in primary cultures of human amniotic cells. Wang SK; Patton DL; Kuo CC J Clin Microbiol; 1992 Oct; 30(10):2551-4. PubMed ID: 1400952 [TBL] [Abstract][Full Text] [Related]
80. Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections. Pitt R; Alexander S; Ison C; Horner P; Hathorn E; Goold P; Woodford N; Cole MJ J Antimicrob Chemother; 2018 Mar; 73(3):680-686. PubMed ID: 29207004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]